FDA 483 - Rohto-Mentholatum (Vietnam) Co., Ltd. - March 16, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Rohto Mentholatum (Vietnam) Co., Ltd. in Binh Duong Province, Vietnam, revealed significant deficiencies in the manufacturing of OTC sterile drug products. The firm's environmental monitoring, aseptic processing controls, media fill simulations, and microbiological testing procedures were found to be inadequate. These issues collectively indicate a lack of robust controls necessary to ensure the sterility and quality of their sterile drug products.
ID · 97566899-df8c-4661-a8c8-8e9a35a50d10